Publications by authors named "Taichi Yoshida"

Claim this Profile
C
Contribution of laparoscopic surgery to the diagnosis of ovarian metastasis from thymoma: A rare case and review of the literature.
Yui Sejimo, Kenichi Makino, Masato Waga, Enami Kaneko, Takeo Hirakawa, Taichi Yoshida

Gynecol Oncol Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration of Nivolumab plus FOLFOX Therapy to a Patient with Gastric Cancer Undergoing Hemodialysis: A Case Report.
Taichi Yoshida, Naoaki Kodama, Tomohiro Matsumoto, Daiki Taguchi, Kazuhiro Shimazu

Intern Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Familial adenomatous polyposis family with clustering of psychiatric disorders.
Masako Funaki, Atsuko Noguchi, Hayahito Ishikawa, Rie Noutomi, Koji Fukuda, Taichi Yoshida

Jpn J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitor restores daily function in patient with microsatellite instability (MSI)-high advanced endometrial cancer and poor performance status.
Ayaka Matsui, Taichi Yoshida, Yuya Takahashi, Koji Fukuda, Kazuhiro Shimazu

Int Cancer Conf J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of bone management agents administered at 12 weeks vs. 4 weeks in patients with bone metastases: A systematic review.
Junya Sato, Makoto Kodaira, Hiroyuki Harada, Haruo Iguchi, Taichi Yoshida

J Oncol Pharm Pract· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 expression in keratinocyte and infiltration of CD4 + T lymphocyte can predict a severe type of erythema multiforme major induced by the anti-PD-1 antibody, pembrolizumab.
Ryohei Kadoi, Taichi Yoshida, Mai Noto, Aya Toyoshima, Sino Fujii

Int Cancer Conf J· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between albumin-bilirubin grade and plasma trough concentrations of regorafenib and its metabolites M-2 and M-5 at steady-state in Japanese patients.
Kazuma Fujita, Daiki Taguchi, Koji Fukuda, Taichi Yoshida, Kazuhiro Shimazu

Invest New Drugs· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent trends in bone metastasis treatments: A historical comparison using the new Katagiri score system.
Kenji Matsuda, Kazuhiro Shimazu, Hanae Shinozaki, Koji Fukuda, Taichi Yoshida

World J Clin Cases· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of hereditary breast and ovarian cancer syndrome of initially presented as cancer of unknown primary with lymph node metastases unveiled by genetic analysis.
Juri Yamada, Koji Fukuda, Tae Sugawara, Kenichi Makino, Kazuhiro Shimazu, Taichi Yoshida

Int Cancer Conf J· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical response of pancreatic cancer bearing a germline BRCA2 p.I3169M fs*48 variant for platinum-based drug and PARP inhibitor.
Risa Akahira, Koji Fukuda, Kazuhiro Shimazu, Taichi Yoshida, Daiki Taguchi

Jpn J Clin Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Course of a Rare Epstein-Barr Virus-Associated Smooth Muscle Tumor and Its Genomic Analysis.
Jun Miyahara, Kazuhiro Shimazu, Ayano Saito, Mitsuru Saito, Koji Fukuda, Taichi Yoshida

Case Rep Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymph-node metastasis from gastric adenocarcinoma in a patient bearing a germ line missense variant MSH2 c.1808A > T (Asp603Val) responds to the immune checkpoint inhibitor pembrolizumab.
Miki Kiyomiya, Koji Fukuda, Kazuhiro Shimazu, Taichi Yoshida, Daiki Taguchi

Jpn J Clin Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-temperature and elastic properties of the 1/1 Tsai-type quasicrystal approximant GdCdinvestigated by ultrasonic measurements.
Taichi Yoshida, Kensuke Jin, Kazuhei Wakiya, Mitsuteru Nakamura, Masahito Yoshizawa

J Phys Condens Matter· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrolyzed deketene curcumin controls regulatory T cell generation and gastric cancer metabolism cooperate with 2-deoxy-d-glucose.
Takashi MaruYama, Hirofumi Miyazaki, Yun-Ji Lim, Jian Gu, Masaki Ishikawa, Taichi Yoshida

Front Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Artery Intimal Sarcoma in a Patient with Lynch Syndrome: Response to an Immune Checkpoint Inhibitor.
Yue Mounai, Taichi Yoshida, Shogo Ito, Koji Fukuda, Kazuhiro Shimazu

Case Rep Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel Lynch syndrome pedigree bearing germ-line MSH2 missense mutation c.1808A>T (Asp603Val).
Risako Sekine, Kazuhiro Shimazu, Daisuke Nakano, Tatsuro Yamaguchi, Yusato Suzuki, Taichi Yoshida

Jpn J Clin Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sudden and severe cardiotoxicity induced with pembrolizumab, its clinical course, therapeutic intervention, and outcome.
Tomohiro Matsumoto, Koji Fukuda, Taichi Yoshida, Kazuhiro Shimazu, Daiki Taguchi

Int Cancer Conf J· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two Cases of ALK-Altered Cancers of Unknown Primary Diagnosed by Immunohistochemistry.
Yoriko Kato, Kazuhiro Shimazu, Koji Fukuda, Taichi Yoshida, Daiki Taguchi

Case Rep Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy and safety of second line and salvage aflibercept for advanced colorectal cancer in Akita prefecture.
Taichi Yoshida, Kentaro Takahashi, Kengo Shibuya, Osamu Muto, Yuko Yoshida

World J Gastrointest Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of colorectal cancer in Diamond-Blackfan syndrome with a ribosomal protein S19 mutation.
Kazuya Kimura, Kazuhiro Shimazu, Tsutomu Toki, Momoko Misawa, Koji Fukuda, Taichi Yoshida

Clin J Gastroenterol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung adenocarcinoma in a patient with Li-Fraumeni syndrome bearing a novel germ-line mutation, TP53R333Vfs*12.
Shodai Takahashi, Kazuhiro Shimazu, Koya Kodama, Koji Fukuda, Taichi Yoshida

Jpn J Clin Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic drug monitoring of regorafenib and its metabolite M5 can predict treatment efficacy and the occurrence of skin toxicities.
Daiki Taguchi, Masahiro Inoue, Koji Fukuda, Taichi Yoshida, Kazuhiro Shimazu, Kazuhiro Yoshida

Int J Clin Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curcumin analog, GO-Y078, overcomes resistance to tumor angiogenesis inhibitors.
Kazuhiro Shimazu, Masahiro Inoue, Shunsuke Sugiyama, Koji Fukuda, Taichi Yoshida

Cancer Sci· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guillain-Barré syndrome in a cancer patient treated with bevacizumab.
Daiki Taguchi, Sachiko Kamada, Taichi Yoshida, Koji Fukuda, Kazuhiro Shimazu

Int Cancer Conf J· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of anti-PD-1 antibody, nivolumab on early gastric cancer.
Koji Fukuda, Taichi Yoshida, Kazuhiro Shimazu, Daiki Taguchi, Masahiro Inoue

Int Cancer Conf J· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis